Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma
Blood Cancer J
.
2023 May 30;13(1):89.
doi: 10.1038/s41408-023-00864-0.
Authors
Rahul Banerjee
1
2
,
Louis Williams
3
,
Joseph R Mikhael
4
Affiliations
1
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. rahul.banerjee.md@gmail.com.
2
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. rahul.banerjee.md@gmail.com.
3
Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
4
Translational Genomics Research Institute (TGen), City of Hope, Phoenix, AZ, USA.
PMID:
37248225
PMCID:
PMC10226974
DOI:
10.1038/s41408-023-00864-0
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / drug therapy
Transplantation, Autologous